K Yoshikawa

678 total citations
24 papers, 568 citations indexed

About

K Yoshikawa is a scholar working on Surgery, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, K Yoshikawa has authored 24 papers receiving a total of 568 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 7 papers in Molecular Biology and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in K Yoshikawa's work include Cardiac Fibrosis and Remodeling (3 papers), Peptidase Inhibition and Analysis (3 papers) and Calpain Protease Function and Regulation (2 papers). K Yoshikawa is often cited by papers focused on Cardiac Fibrosis and Remodeling (3 papers), Peptidase Inhibition and Analysis (3 papers) and Calpain Protease Function and Regulation (2 papers). K Yoshikawa collaborates with scholars based in Japan and United States. K Yoshikawa's co-authors include Kozi Asada, Motoko Takahashi, Hirofumi Usui, Masao Takeda, Miki Imazu, Teiji Imaoka, N Yashiro, Shigeru Furui, A Tasaka and Yuji Itai and has published in prestigious journals such as Journal of Biological Chemistry, Radiology and FEBS Letters.

In The Last Decade

K Yoshikawa

24 papers receiving 540 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K Yoshikawa Japan 12 222 92 90 86 75 24 568
Anne Bravard France 18 760 3.4× 22 0.2× 48 0.5× 109 1.3× 74 1.0× 25 1.1k
Colin G.D. Morley United States 15 392 1.8× 22 0.2× 218 2.4× 66 0.8× 27 0.4× 30 1.0k
Minako Takahashi Japan 13 219 1.0× 25 0.3× 22 0.2× 28 0.3× 36 0.5× 23 633
Olga Salcher Germany 11 220 1.0× 49 0.5× 42 0.5× 15 0.2× 20 0.3× 19 507
Naomi Ishii Japan 15 183 0.8× 36 0.4× 39 0.4× 41 0.5× 23 0.3× 45 572
Maria Schwarz Germany 15 147 0.7× 12 0.1× 22 0.2× 36 0.4× 119 1.6× 40 575
Chunfeng Yang China 13 174 0.8× 15 0.2× 39 0.4× 42 0.5× 23 0.3× 44 444
Paul A. Charp United States 7 262 1.2× 45 0.5× 36 0.4× 8 0.1× 22 0.3× 10 519
I.Y. Huang United States 16 428 1.9× 7 0.1× 50 0.6× 59 0.7× 132 1.8× 20 1.1k
Ning Huang China 13 241 1.1× 14 0.2× 37 0.4× 27 0.3× 25 0.3× 39 569

Countries citing papers authored by K Yoshikawa

Since Specialization
Citations

This map shows the geographic impact of K Yoshikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K Yoshikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K Yoshikawa more than expected).

Fields of papers citing papers by K Yoshikawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K Yoshikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K Yoshikawa. The network helps show where K Yoshikawa may publish in the future.

Co-authorship network of co-authors of K Yoshikawa

This figure shows the co-authorship network connecting the top 25 collaborators of K Yoshikawa. A scholar is included among the top collaborators of K Yoshikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K Yoshikawa. K Yoshikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Semba, Takashi, Eiji Sugihara, Sayaka Ueno, et al.. (2018). Periostin antisense oligonucleotide suppresses bleomycin‐induced formation of a lung premetastatic niche for melanoma. Cancer Science. 109(5). 1447–1454. 16 indexed citations
2.
Kobayashi, Tetsu, Corina N. D’Alessandro‐Gabazza, Hajime Fujimoto, et al.. (2017). Oligonucleotide-targeting periostin ameliorates pulmonary fibrosis. Gene Therapy. 24(11). 706–716. 23 indexed citations
3.
Nakama, Takahito, Shigeo Yoshida, Keijiro Ishikawa, et al.. (2017). Therapeutic Effect of Novel Single-Stranded RNAi Agent Targeting Periostin in Eyes with Retinal Neovascularization. Molecular Therapy — Nucleic Acids. 6. 279–289. 18 indexed citations
4.
Takai, Shinji, et al.. (2017). Periostin antisense oligonucleotide prevents adhesion formation after surgery in mice. Journal of Pharmacological Sciences. 133(2). 65–69. 9 indexed citations
5.
Nakama, Takahito, Shigeo Yoshida, Keijiro Ishikawa, et al.. (2014). Inhibition of choroidal fibrovascular membrane formation by new class of RNA interference therapeutic agent targeting periostin. Gene Therapy. 22(2). 127–137. 36 indexed citations
6.
Adachi, H., Yuji Hirai, Minori Enomoto, et al.. (2013). High Level of Plasma Remnant-like Particle Cholesterol May Predispose to Development of Hypertension in Normotensive Subjects. American Journal of Hypertension. 26(6). 793–798. 17 indexed citations
7.
Fukami, Ako, Hisashi Adachi, Masaru Enomoto, et al.. (2011). P2-90 High levels of plasma homocysteine predicts development of hypertension in a general population. The Tanushimaru Study. Journal of Epidemiology & Community Health. 65(Suppl 1). A245.1–A245. 1 indexed citations
8.
Kumagae, Shunichi, H. Adachi, David R. Jacobs, et al.. (2010). High Level of Plasma Endothelin-1 Predicts Development of Hypertension in Normotensive Subjects. American Journal of Hypertension. 23(10). 1103–1107. 11 indexed citations
9.
Tsumura, Hiroaki, et al.. (2002). Failure of endoscopic removal of common bile duct stones due to endo-clip migration following laparoscopic cholecystectomy. Journal of Hepato-Biliary-Pancreatic Surgery. 9(2). 274–277. 29 indexed citations
10.
Yoshikawa, K, et al.. (1994). [A case of gallbladder adenoma based on cholesterol polyp].. PubMed. 91(8). 1365–8. 1 indexed citations
11.
Kojima, Shuji, et al.. (1994). Inhibition of Carbon Tetrachloride-Induced Hepatotoxicity by Neopterins.. Biological and Pharmaceutical Bulletin. 17(7). 914–916. 3 indexed citations
12.
Yoshikawa, K, et al.. (1993). A Case of Solitary Splenic Abscess Caused by Salmonella Enteritidis and Cured Completely by Antibiotic Therapy Alone. Kansenshogaku zasshi. 67(4). 366–370. 3 indexed citations
13.
Kanakura, Yuzuru, et al.. (1990). Differences in irradiation susceptibility and turnover between mucosal and connective tissue-type mast cells of mice.. PubMed. 18(7). 843–7. 27 indexed citations
14.
Yoshikawa, K, Hirofumi Usui, Miki Imazu, Haruhisa Tsukamoto, & Masao Takeda. (1985). Comparison of tyrosine protein kinases in membrane fractions from mouse liver and Ehrlich ascites tumor.. Journal of Biological Chemistry. 260(28). 15091–15099. 19 indexed citations
15.
Usui, Hirofumi, K Yoshikawa, Michinori Imazu, Haruhisa Tsukamoto, & Masao Takeda. (1985). Comparison of tyrosine phosphorylation of proteins by membrane fractions from mouse liver, ehrlich ascites tumor and MH134 hepatoma. FEBS Letters. 184(1). 60–64. 9 indexed citations
16.
Usui, Hirofumi, et al.. (1984). Effects of Polyamine Hydrochlorides on Dephosphorylation of Phosphorylated H2B Histone Integrated into Nucleosome Core Particles1. The Journal of Biochemistry. 95(2). 597–600. 3 indexed citations
17.
Yoshikawa, K, Hirofumi Usui, Michinori Imazu, Masao Takeda, & Setsuro Ebashi. (1983). The effect of heart and skeletal muscle troponin complexes and calmodulin on the Ca2+‐dependent reactions of phosphorylase kinase isoenzymes. European Journal of Biochemistry. 136(2). 413–419. 5 indexed citations
18.
Usui, Hirofumi, et al.. (1983). Phosphoprotein phosphatases in human erythrocyte cytosol.. Journal of Biological Chemistry. 258(17). 10455–10463. 46 indexed citations
19.
Yoshikawa, K, et al.. (1977). Primary leiomyosarcoma of the liver.. PubMed. 3(2). 197–202. 7 indexed citations
20.
Asada, Kozi, et al.. (1975). Superoxide dismutases from a blue-green alga, Plectonema boryanum.. Journal of Biological Chemistry. 250(8). 2801–2807. 242 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026